Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/1996
12/11/1996EP0746312A1 Guanylhydrazones for treating inflammatory conditions
12/11/1996EP0695305A4 Method of forming oligonucleotides
12/11/1996EP0663906B1 Method of preparing taxane derivatives
12/11/1996EP0642529B1 11beta-substituted 14,17-ethanoestratrienes, process for preparing these compounds and their use for preparing medicaments
12/11/1996EP0437556B1 Substitution analogues of magainin peptides
12/11/1996CN1137799A Glucosamine disaccharides, method for their preparation pharmaceutical composition comprising same and their use
12/11/1996CN1137525A Naphthyl compounds, intermediates, compositions, and methods
12/11/1996CN1033509C Process for preparation of water soluble camptothecin analogs
12/10/1996US5583242 Use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation
12/10/1996US5583224 Isolation and elucidation of cephalostatin 7, 8 and 9
12/10/1996US5583222 Antiinflammatory agents for treatment of skin disorders
12/10/1996US5583221 Antiinflammatory agents, cardiovascular disorders, viricides, fungicides
12/10/1996US5583220 Pyrole nitrogen-substituted texaphyrins
12/10/1996US5583208 Ganglioside GM3 derivatives containing fluorine in ceramide portion
12/10/1996US5583206 Chelating polymers
12/10/1996US5583160 Exposing cells to dimethyl sphingosine until preferential level of cell death has occured
12/10/1996US5583148 Bis-acyloxymethyl derivatives
12/10/1996US5583137 Heterocyclic compounds for enhancing antitumor activity
12/10/1996US5583135 Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them
12/10/1996US5583133 Anticoagulants
12/10/1996US5583125 25-Carboxylic acid derivatives in the vitamin D series, process for their production, intermediate products for these processes, pharmaceutical preparations containing these derivatives as well as their use for the production of pharmaceutical agents
12/10/1996US5583018 Rapamycin derivative process for its preparation and its use
12/10/1996US5582995 Methods of screening for compounds which inhibit the direct binding of Ras to Raf
12/10/1996US5582823 Methods of treating bacterial inflammation and granulocytopoiesis by administering human pluripotent granulocyte colony-stimulating factor
12/10/1996US5582822 Cyclic administration of purified genetically engineered human interleukins
12/10/1996US5582172 Intravascular administering a particle carrier comprising an organic inner core surface grafted with carbohydrates specific bonding to lymph nodes
12/10/1996CA2032254C Glycerol derivatives, a preparation process of the same and therapeutical compositions containing them
12/10/1996CA2032224C 3-(n-methyl-n-alkyl)-amino 2-methoxymethylene propan 1-ol derivatives, a preparation process of the same and therapeutical compositions containing them
12/10/1996CA1338781C Ligands and methods for augmenting b-cell proliferation
12/08/1996CA2178184A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2178182A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/07/1996CA2176191A1 Prodrugs of paclitaxel derivatives
12/07/1996CA2175854A1 Rar(gamma)-specific retinobenzoic acid derivatives
12/05/1996WO1996038579A1 High-affinity oligonucleotide ligands to growth factors
12/05/1996WO1996038558A2 A human purinergic p2u receptor
12/05/1996WO1996038557A1 Hepatocyte growth factor receptor antagonists and uses thereof
12/05/1996WO1996038556A2 Deltap62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer
12/05/1996WO1996038477A1 Novel antiproliferative protein from bacillus thuringiensis var. thuringiensis
12/05/1996WO1996038474A2 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide
12/05/1996WO1996038461A1 Cleavage of rna using metal complexes
12/05/1996WO1996038457A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996WO1996038449A1 Water soluble camptothecin analogs
12/05/1996WO1996038446A1 Fused polycyclic heterocycle derivatives
12/05/1996WO1996038434A1 Tricyclic inhibitors of matrix metalloproteinases
12/05/1996WO1996038426A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996WO1996038172A1 Connective tissue growth factor
12/05/1996WO1996038168A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996WO1996038146A1 Water soluble camptothecin analogs
12/05/1996WO1996038145A1 Methods for inhibiting vascular smooth muscle cell migration
12/05/1996WO1996038138A1 Novel taxoids
12/05/1996CA2223276A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996CA2222968A1 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide
12/05/1996CA2222609A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996CA2222292A1 Methods for inhibiting vascular smooth muscle cell migration
12/05/1996CA2222147A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996CA2221128A1 Hydrolysis and photocleavage of nucleic acid using a metal complex
12/05/1996CA2220955A1 A novel human purinergic p2u receptor
12/05/1996CA2220040A1 Tricyclic inhibitors of matrix metalloproteinases
12/05/1996CA2219861A1 .delta.p62, variants thereof, nucleic acid sequences and uses thereof
12/04/1996EP0745583A1 Alkoxy aryl compounds with affinity to the melatonine receptors, process for their preparation and pharmaceutical compositions containing them
12/04/1996EP0745390A2 Polymeric prodrugs for beta-lactamase and uses thereof
12/04/1996EP0745384A2 Methods for inhibiting vascular smooth muscle cell migration
12/04/1996EP0745134A1 Nucleic acid delivery system, method of synthesis and uses thereof
12/04/1996EP0745131A1 Targeting gene therapy
12/04/1996EP0745124A1 Mammalian cell cycle protein
12/04/1996EP0745094A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
12/04/1996EP0745092A1 Peptide inhibitors of urokinase receptor activity
12/04/1996EP0745087A1 Novel cytotoxic macrolides, their isolation from a marine sponge and their use as antitumor agents
12/04/1996EP0745085A1 Texaphyrin metal complexes having improved functionalization
12/04/1996EP0745078A1 Enantiomerically pure(-)-liarozole
12/04/1996EP0745077A1 Enantiomerically pure (+)-liarozole
12/04/1996EP0745075A1 6-substituted mycophenolic and derivatives with immunosuppressive activity
12/04/1996EP0745074A1 4-amino derivatives of mycophenolic acid with immunosuppressant activity
12/04/1996EP0745073A1 5-substituted derivatives of mycophenolic acid
12/04/1996EP0745071A1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity
12/04/1996EP0745068A1 Heteroaryl-substituted deoxy glycero-phosphoethanolamines
12/04/1996EP0744894A1 Self-assembling multimeric nucleic acid constructs
12/04/1996EP0621785B1 Use of aqueous solutions containing peroxobisulphate ions for the treatment of malignant cells
12/04/1996EP0547191B1 Particulate vector having selective tropism, method of preparation and pharmaceutical composition
12/04/1996EP0479920B1 Novel antibodies reactive with human carcinomas
12/04/1996EP0275297B1 Bisplatinum complexes as chemotherapeutic agents
12/04/1996CN1137268A Amidino derivatives useful as nitric oxide synthase inhibitors
12/04/1996CN1137037A Quinazoline derivatives
12/04/1996CN1137035A Basic group substituted benzoyl guanidine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same
12/03/1996US5581006 Synthesis of 19-nor vitamin D compounds
12/03/1996US5580998 Process for preparing taxoids
12/03/1996US5580997 Baccatin III derivatives
12/03/1996US5580899 Stably associate with lipid carrier for improved delivery
12/03/1996US5580878 Treating sleep disorders
12/03/1996US5580870 Quinazoline derivatives
12/03/1996US5580774 Anticarcinogenic agents
12/03/1996US5580755 Human pluripotent granulocyte colony-stimulating factor
12/03/1996US5580753 DNA encoding the human cytokine, interleukin-9
12/03/1996US5580543 Texaphyrins as radiation sensitizers
12/03/1996CA2028140C Novel bacteriocin compositions for use as enhanced broad range
12/01/1996CA2177644A1 Polymeric prodrugs for beta-lactamase and uses thereof
11/1996
11/28/1996WO1996037626A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
11/28/1996WO1996037621A2 Multimeric proteins
11/28/1996WO1996037609A1 A gene switch comprising an ecdysone receptor
11/28/1996WO1996037496A1 Substituted camptothecin derivatives and process for their preparation
1 ... 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 ... 2211